106 related articles for article (PubMed ID: 16180994)
1. A short-incubation reporter-gene assay for high-throughput screening of estrogen receptor-alpha antagonists.
Shi X; Zheng W; Schneeweis JE; Fischer PA; Strulovici B; Peekhaus NT
Assay Drug Dev Technol; 2005 Aug; 3(4):393-400. PubMed ID: 16180994
[TBL] [Abstract][Full Text] [Related]
2. A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format.
Peekhaus NT; Ferrer M; Chang T; Kornienko O; Schneeweis JE; Smith TS; Hoffman I; Mitnaul LJ; Chin J; Fischer PA; Blizzard TA; Birzin ET; Chan W; Inglese J; Strulovici B; Rohrer SP; Schaeffer JM
Assay Drug Dev Technol; 2003 Dec; 1(6):789-800. PubMed ID: 15090225
[TBL] [Abstract][Full Text] [Related]
3. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW
Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768
[TBL] [Abstract][Full Text] [Related]
4. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
[TBL] [Abstract][Full Text] [Related]
5. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
Levy N; Zhao X; Tang H; Jaffe RB; Speed TP; Leitman DC
Endocrinology; 2007 Jul; 148(7):3449-58. PubMed ID: 17395694
[TBL] [Abstract][Full Text] [Related]
6. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.
Reiter R; Oh AS; Wellstein A; Riegel AT
Oncogene; 2004 Jan; 23(2):403-9. PubMed ID: 14691461
[TBL] [Abstract][Full Text] [Related]
7. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
[TBL] [Abstract][Full Text] [Related]
8. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
9. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
10. A Screening Assay Cascade to Identify and Characterize Novel Selective Estrogen Receptor Downregulators (SERDs).
Callis R; Rabow A; Tonge M; Bradbury R; Challinor M; Roberts K; Jones K; Walker G
J Biomol Screen; 2015 Jul; 20(6):748-59. PubMed ID: 25851036
[TBL] [Abstract][Full Text] [Related]
11. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
[TBL] [Abstract][Full Text] [Related]
12. A genetically encoded fluorescent indicator capable of discriminating estrogen agonists from antagonists in living cells.
Awais M; Sato M; Sasaki K; Umezawa Y
Anal Chem; 2004 Apr; 76(8):2181-6. PubMed ID: 15080726
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
14. Raloxifene and ICI182,780 increase estrogen receptor-alpha association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12.
Lupien M; Jeyakumar M; Hébert E; Hilmi K; Cotnoir-White D; Loch C; Auger A; Dayan G; Pinard GA; Wurtz JM; Moras D; Katzenellenbogen J; Mader S
Mol Endocrinol; 2007 Apr; 21(4):797-816. PubMed ID: 17299137
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line.
Eertmans F; Dhooge W; De Wever O; Bracke M; Comhaire F; Kaufman JM
J Cell Physiol; 2007 Sep; 212(3):583-90. PubMed ID: 17458895
[TBL] [Abstract][Full Text] [Related]
16. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
17. Compound profiling using a panel of steroid hormone receptor cell-based assays.
Wilkinson JM; Hayes S; Thompson D; Whitney P; Bi K
J Biomol Screen; 2008 Sep; 13(8):755-65. PubMed ID: 18753690
[TBL] [Abstract][Full Text] [Related]
18. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
[TBL] [Abstract][Full Text] [Related]
19. Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.
Gielen SC; Burger CW; Kühne LC; Hanifi-Moghaddam P; Blok LJ
J Soc Gynecol Investig; 2005 Oct; 12(7):e55-67. PubMed ID: 16202921
[TBL] [Abstract][Full Text] [Related]
20. Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes.
Schwartz JA; Liu G; Brooks SC
Biochem Biophys Res Commun; 1998 Dec; 253(1):38-43. PubMed ID: 9875216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
